You are here

  • Home
  • Archive
  • Volume 27, Issue 4
  • Factors Predicting Use of Neoadjuvant Chemotherapy Compared With Primary Debulking Surgery in Advanced Stage Ovarian Cancer—A National Cancer Database Study

Article info

Article menu
Download PDFPDF
Ovarian Cancer
Factors Predicting Use of Neoadjuvant Chemotherapy Compared With Primary Debulking Surgery in Advanced Stage Ovarian Cancer—A National Cancer Database Study

Authors

  1. Address correspondence and reprint requests to: Gary S. Leiserowitz, MD, MS, Department of Obstetrics and Gynecology, 4860 Y St, Suite 2500, Sacramento, CA 95817. E-mail: gsleiserowitz{at}ucdavis.edu.

Citation

Leiserowitz GS, Lin JF, Tergas AI, et al
Factors Predicting Use of Neoadjuvant Chemotherapy Compared With Primary Debulking Surgery in Advanced Stage Ovarian Cancer—A National Cancer Database Study
International Journal of Gynecologic Cancer 2017;27:675-683.

Publication history

  • Received October 6, 2016
  • Accepted December 8, 2016
  • First published May 1, 2017.
Online issue publication 
May 01, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2017 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.